Independent Director · ZEVRA THERAPEUTICS, INC. (ZVRA)

John B. Bode director compensation at Zevra Therapeutics: $247K

Fiscal year 2025 director compensation for John B. Bode at ZEVRA THERAPEUTICS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get John B. Bode’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track John B. Bode and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

ZEVRA THERAPEUTICS Director Compensation Table · all 3 fiscal years held
In US dollars, as ZEVRA THERAPEUTICS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$59,735—$187,178—$246,913
FY2024$61,500—$180,442—$241,942
FY2023$41,598—$222,710—$264,308

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ZEVRA THERAPEUTICS, INC. DEF 14A filed April 20, 2026, accession 0001434647-26-000025, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ZEVRA THERAPEUTICS, INC. filed document, accession 0001434647-26-000025. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.

Get the ZEVRA THERAPEUTICS Board Governance Report

$246,913 John B. Bode, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

ZEVRA THERAPEUTICS pays directors a $45,000 cash retainer and $30,000 in Options.

The rest of the ZEVRA THERAPEUTICS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alicia SecorIndependent Director$264,878
Alvin Shih, M.DIndependent Director$244,678
Corey WattonIndependent Director$249,678
Douglas W. CalderIndependent Director$243,992
Tamara A. FavoritoChair of the Board$304,678
Thomas D. AndersonIndependent Director$252,178

The full ZEVRA THERAPEUTICS compensation record

free company brief

This page is one director within ZEVRA THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.

Order ZVRA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report